TickerFactsScreenerDevelopers

Theravance Biopharma, Inc. (TBPH) — Net Income

Annual figures by fiscal year, from SEC filings.

2012: -$9.57M2013: -$156.28M2014: -$237.04M2015: -$182.22M2016: -$190.67M2017: -$285.40M2018: -$215.52M2019: -$236.46M2020: -$278.02M2021: -$199.43M2022: $872.13M2023: -$55.19M2024: -$56.42M2025: $105.89M$105.89M
2012Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$105.89M+287.7%
2024-$56.42M-2.2%
2023-$55.19M-106.3%
2022$872.13M+537.3%
2021-$199.43M+28.3%
2020-$278.02M-17.6%
2019-$236.46M-9.7%
2018-$215.52M+24.5%
2017-$285.40M-49.7%
2016-$190.67M-4.6%
2015-$182.22M+23.1%
2014-$237.04M-51.7%
2013-$156.28M-1532.2%
2012-$9.57M—